Moment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Moment Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$230K	Sell	4,000 -633	-14%	-$36.3K	0.04%	95
2026 Q1	$281K	Hold	4,633	–	–	0.05%	92
2025 Q4	$250K	Hold	4,633	–	–	0.05%	91
2025 Q3	$209K	Hold	4,633	–	–	0.04%	114
2025 Q2	$214K	Hold	4,633	–	–	0.04%	107
2025 Q1	$283K	Hold	4,633	–	–	0.06%	94
2024 Q4	$262K	Buy	+4,633	New	+$259K	0.05%	104

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Moment Partners's BMY Position: Q2 2026 in Review

Moment Partners reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q2 2026, selling an estimated $36.3K and leaving 4,000 shares worth $230K. The position accounts for 0.04% of the portfolio, ranked #95.

Moment Partners first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $283K in Q1 2025. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Moment Partners held 4,000 shares of Bristol-Myers Squibb worth $230K as of Q2 2026.
Moment Partners sold 633 Bristol-Myers Squibb shares in Q2 2026, an estimated $36.3K.
Bristol-Myers Squibb made up 0.04% of Moment Partners's portfolio in Q2 2026, its #95 holding.
Moment Partners first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
Moment Partners's Bristol-Myers Squibb position peaked at $283K in Q1 2025.
1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Moment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.